Published on: 2026-06-12
Rocket Lab (NASDAQ: RKLB) will join the Nasdaq-100 before the opening bell on Monday, 22 June, capping a run that has turned a once-speculative launch company into a roughly $69 billion member of one of the world’s most tracked equity benchmarks.
The stock rose about 11% after Nasdaq named it in the June quarterly rebalance late on 11 June, alongside Astera Labs, CoreWeave, Nebius and Teradyne.
Inclusion hands Rocket Lab a base of buyers it did not have to win on fundamentals. It also resets the standard the company is measured against.
With a market value near $69 billion built on annual revenue still under $1 billion, the question moves from whether Rocket Lab belongs among large-cap technology names to whether its growth can justify the price the index now enshrines.
| Metric | Value |
|---|---|
| Ticker | NASDAQ: RKLB |
| Share price | About $115 |
| Move on inclusion news | Up about 11% |
| Market cap | ~$69 billion |
| 52-week range | $25.24–$151.00 |
| All-time closing high | $150.23, 27 May 2026 |
| Nasdaq-100 effective date | 22 June 2026, pre-market |
| One-year return | About +200% |
| Backlog | $2.2 billion |
Snapshot as of the 11 June 2026 session. Market figures move; refresh before publishing.
Nasdaq announced the results of its June 2026 quarterly review after the close on 11 June.
Five names enter the Nasdaq-100 index before the open on 22 June: Rocket Lab, connectivity-chip maker Astera Labs, cloud-computing firms CoreWeave and Nebius, and test-equipment maker Teradyne.
Five leave Nasdaq-100: Charter Communications, Cognizant, Insmed, Verisk Analytics and Zscaler.
Several of the additions are tied to AI infrastructure; Rocket Lab is the clear space name in the group, and its arrival reflects how far the sector has moved from the periphery of public markets.
The timing carries its own symbolism: the company recently produced its 100th Electron rocket, the small-satellite vehicle that built its launch business across pads in New Zealand and Virginia.
The mechanical consequence of inclusion is rules-based demand that does not depend primarily on a discretionary view of Rocket Lab’s valuation.
Nasdaq says the Nasdaq-100 is tracked by more than 200 investment products with over $800 billion in assets under management globally.
Funds that physically replicate the benchmark will need exposure to Rocket Lab once the change takes effect, while benchmarked active managers and index-linked strategies gain a clearer mandate to own or reference the stock.
That demand is rules-based rather than valuation-led, which is why index additions often find support into an effective date. The effect should not be overstated: some Nasdaq-100-linked exposure is held through derivatives, swaps, futures or transition baskets rather than direct share purchases.
Still, inclusion changes Rocket Lab’s investor base by pulling the stock deeper into the institutional and index-linked ecosystem that anchors large-cap growth equities.
The harder part begins once the automatic buying clears. A market value near $69 billion against revenue still under $1 billion places Rocket Lab among the more richly valued names in the index on a sales basis, and the company is not yet consistently profitable.
The shares already sit well off the all-time closing high of $150.23 reached on 27 May, and with a beta well above two, RKLB moves far more sharply than the benchmark it is entering.
The fundamental backdrop supports the growth narrative without settling the valuation question.
The order backlog stands at about $2.2 billion across more than 70 contracted missions, the Space Systems arm has expanded through the Motiv Space Systems acquisition and the Gauss propulsion platform, and the medium-lift Neutron rocket remains the swing factor in the multi-year revenue case.
None of that is new to the market, and none of it changes on inclusion day. What changes is the level of scrutiny that index membership invites on execution, capital allocation and the cadence of Neutron’s development.
Rocket Lab enters the index in the same week that SpaceX began trading on Nasdaq.
SpaceX priced its initial public offering at $135 a share and raised about $75 billion, the largest IPO on record and a listing that opened at a valuation near $1.75 trillion.
Under a revised Nasdaq methodology that shortens the waiting period for large new listings, SpaceX could itself qualify for the Nasdaq-100 as early as July.
The sequence underlines a structural shift. Space exposure is migrating from a speculative corner of the market into the benchmarks that anchor mainstream portfolios. For Rocket Lab, the arrival of a far larger pure-play peer is a double signal: validation of the sector’s investability, and the prospect of a dominant comparator drawing capital and attention once it is publicly traded.
Index addition is a catalyst with a known shape. The run into the effective date is often supported by anticipatory and passive buying, and the period just after can bring profit-taking once that demand is satisfied.
Beyond the mechanics, membership ties Rocket Lab’s trading more closely to broad technology sentiment and index flows than to space-specific news alone.
The investor question is no longer whether Rocket Lab is growing. It is whether revenue, backlog, the Neutron roadmap and the Space Systems expansion can grow into the expectations that ride alongside Nasdaq-100 membership.
